Literature DB >> 21311556

Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy.

S Tuve, J Gayoso, C Scheid, J Radke, A Kiani, D Serrano, U Platzbecker, G Rodríguez-Macías, M Wermke, U Holtick, P Balsalobre, J M Middeke, N Shayegi, J M Chemnitz, A Krause, N Gruner, M Füssel, J Schetelig, C Thiede, G Ehninger, M Hallek, J L Díez-Martín, M Bornhäuser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21311556     DOI： 10.1038/leu.2011.11

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

Review 1.  Transplantation tolerance: from theory to clinic.

Authors:  Ephraim J Fuchs
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

2.  Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas.

Authors:  L Castagna; S Bramanti; S Furst; L Giordano; R Crocchiolo; B Sarina; E Mauro; L Morabito; R Bouabdallah; D Coso; M Balzarotti; F Broussais; J El-Cheikh; C C Stella; E Brusamolino; D Blaise; A Santoro
Journal:  Bone Marrow Transplant       Date:  2014-09-15       Impact factor: 5.483

3.  Innovative platforms for haploidentical stem cell transplantation: the role of unmanipulated donor graft.

Authors:  Fabio Ciceri; Marco Bregni; Jacopo Peccatori
Journal:  J Cancer       Date:  2011-06-03       Impact factor: 4.207

4.  Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation.

Authors:  Michael Slade; Scott Goldsmith; Rizwan Romee; John F DiPersio; Erik R Dubberke; Peter Westervelt; Geoffrey L Uy; Steven J Lawrence
Journal:  Transpl Infect Dis       Date:  2016-12-28       Impact factor: 2.228
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.